Insight Molecular Diagnostics Inc. (IMDX): Free Cash Flow

Operating cash flow minus capital expenditures for the same annual period and currency, computed by TickerFacts from the filed figures. A simple proxy, not a reported figure; a year without both inputs is left out.

-$25.37M
Year ended 2025-12-31
2014-12-31: -$1.17M2015-12-31: -$4.73M2016-12-31: -$7.63M2017-12-31: -$13.48M2018-12-31: -$11.68M2019-12-31: -$20.63M2020-12-31: -$27.21M2021-12-31: -$38.19M2022-12-31: -$49.91M2023-12-31: -$23.61M2024-12-31: -$21.20M2025-12-31: -$25.37M-$25.37M
2014-12-31 Free Cash Flow (USD) 2025-12-31
Period endedFree Cash FlowChange YoYSource filing
2025-12-31-$25.37Mn/m2026-03-26, From 2025-01-01
2024-12-31-$21.20Mn/m2026-03-26, From 2024-01-01
2023-12-31-$23.61Mn/m2025-03-24, From 2023-01-01
2022-12-31-$49.91Mn/m2024-04-16, From 2022-01-01
2021-12-31-$38.19Mn/m2023-04-12, From 2021-01-01
2020-12-31-$27.21Mn/m2022-03-11, From 2020-01-01
2019-12-31-$20.63Mn/m2021-03-19, From 2019-01-01
2018-12-31-$11.68Mn/m2020-03-26, From 2018-01-01
2017-12-31-$13.48Mn/m2019-04-01, From 2017-01-01
2016-12-31-$7.63Mn/m2018-04-02, From 2016-01-01
2015-12-31-$4.73Mn/m2018-04-02, From 2015-01-01
2014-12-31-$1.17Mn/a2017-02-27, From 2014-01-01

Free Cash Flow at similar companies

Companies with the same SEC industry code (In Vitro & In Vivo Diagnostic Substances), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

CompanyYear endedFree Cash FlowChange YoY
Insight Molecular Diagnostics Inc. (IMDX)2025-12-31-$25.37Mn/m
Aspira Women's Health Inc. (AWHL)2025-12-31-$7.04Mn/m
Volitionrx Ltd (VNRX)2025-12-31-$19.77Mn/m
Celldex Therapeutics, Inc. (CLDX)2025-12-31-$213.66Mn/m
Immucell Corp (ICCC)2025-12-31$1.22Mn/m
Alpha Teknova, Inc. (TKNO)2025-12-31-$9.79Mn/m
Intellia Therapeutics, Inc. (NTLA)2025-12-31-$395.87Mn/m
Neogen Corp (NEOG)2026-05-31$31.90Mn/m
Cardio Diagnostics Holdings, Inc. (CDIO)2025-12-31-$5.91Mn/m

Compare IMDX, AWHL, VNRX, CLDX side by side · Screen every company in In Vitro & In Vivo Diagnostic Substances ↗